複製鏈接
請複製以下鏈接發送給好友
https://baike.baidu.hk/item/夏維波/9870427
複製
複製成功

夏維波

（北京協和醫院內分泌科主任醫師）

鎖定
夏維波，醫學博士，主任醫師，教授，博士研究生導師。現任中國醫學科學院北京協和醫院內分泌科主任，國家衞健委內分泌重點實驗室主任，中華醫學會理事、骨質疏鬆和骨礦鹽疾病分會第五屆主任委員，中華醫學會內分泌分會常委，中國醫師協會內分泌專業委員會常委，北京醫學會內分泌分會副主任委員、骨質疏鬆和骨礦鹽疾病分會常委，國際骨質疏鬆基金會科學顧問委員會理事，亞太骨質疏鬆聯盟理事。 [1-2] 
中文名
夏維波
國    籍
中國
畢業院校
中國協和醫科大學
學    歷
醫學博士
教學職稱
教授
臨牀職稱
主任醫師
執業地點
北京協和醫院
專    業
內分泌
擅長領域
內分泌和代謝疾病

目錄

  1. 1 擅長領域
  2. 2 教育經歷
  3. 3 工作經歷
  4. 4 社會任職
  5. 5 雜誌編委
  1. 6 學術著作編委
  2. 7 獲獎及榮譽稱號
  3. 8 主要學術成就
  4. 9 主要承擔科研項目
  1. 10 第一或通訊作者SCI文章目錄
  2. 11 著作譯作
  3. 12 科普宣傳

夏維波擅長領域

內分泌和代謝疾病的臨牀和研究工作；
對疑難和罕見內分泌代謝疾病的診療；
對代謝性骨病、甲狀腺疾病、糖尿病、垂體和腎上腺疾病、生長髮育異常疾病的診療。 [1] 

夏維波教育經歷

1983年至1988年 寧夏醫學院醫療系 學士
1992年至1995年 大連醫科大學內科學 碩士
1995年至1998年 中國協和醫科大學內分泌 博士 [1] 

夏維波工作經歷

1988年-1992年 寧夏鹽池縣醫院內科 住院醫師
1995年-2020年 中國醫學科學院北京協和醫院 主治醫師，副主任醫師，主任醫師，博士生導師。
2000年-2001年 日本東京大學醫學部 訪問學者
現任中國醫學科學院北京協和醫院內分泌科主任 [1] 

夏維波社會任職

中華醫學會理事
中華醫學會骨質疏鬆和骨礦鹽疾病分會第五屆主任委員
中華醫學會內分泌分會常委
中國醫師協會內分泌專業委員會常委
北京醫學會內分泌分會副主任委員
北京醫學會骨質疏鬆和骨礦鹽疾病分會常委
國際骨質疏鬆基金會科學顧問委員會理事
亞太骨質疏鬆聯盟理事 [1] 

夏維波雜誌編委

《中華骨質疏鬆和骨礦鹽疾病雜誌》副總編、編輯部主任
《中華內分泌和代謝雜誌》編委
《協和醫學雜誌》編委
《Journal of Bone and Mineral Research》編委
《Bone》編委
《Current Osteoporosis Reports》編委
《Osteoporosis and Sarcopenia》編委
《Journal of Orthopaedic Translation》編委 [1] 

夏維波學術著作編委

《骨質疏鬆症防控指南》主編
《臨牀骨密度測量應用手冊》主編
《骨質疏鬆症防治》主編
《內分泌科精要》主編
《骨質疏鬆症》副主編 [1] 

夏維波獲獎及榮譽稱號

國家科技進步獎（二等獎，2002）
華夏醫學科技獎（一等獎，2019）
高校科技進步獎（二等獎，2019）
中華醫學獎（三等獎，2019） [1] 

夏維波主要學術成就

國內多項骨質疏鬆症的流行病學研究和新藥臨牀研究。與國家疾控中心合作完成了全國骨質疏鬆症和骨折的流行病學研究（COPS）。在國內引進高分辨外周定量CT檢查，並建立了中國人羣的正常參考值並用於多種疾病的研究。
在國內報道了10餘種遺傳性內分泌代謝疾病，並因此獲得華夏醫學進步獎，高校科技進步獎和中華醫學獎等。
編寫了《原發性骨質疏鬆症診療指南》、《原發性甲狀旁腺功能亢進症診療指南》、《甲狀旁腺功能減退症診療指南》、《維生素D及其類似物臨牀應用專家共識》、《骨質疏鬆性椎體壓縮性骨折診療與管理專家共識》和《糖尿病骨折風險管理中國專家共識》等多部疾病診療指南和共識。 [1] 

夏維波主要承擔科研項目

承擔國家自然科學基金6項，北京自然科學基金重點項目1項，國家新藥創制平台項目子項目1項，國家科技支撐計劃分課題1項等。 [1] 

夏維波第一或通訊作者SCI文章目錄

發表中文科技論文200餘篇，英文SCI論文100餘篇，其中部分論文（近5年）如下：
Year-2020
  1. Wang Y, Wang O, Nie M, Li Y, Jiang Y, Li M, Xia W, Xing X. CLINICAL AND GENETIC FINDINGS IN A CHINESE COHORT OF PATIENTS WITH DIGEORGE SYNDROME-RELATED HYPOPARATHYROIDISM. Endocr Pract. 2020 Feb 11. doi: 10.4158/EP-2019-0498. [Epub ahead of print] PubMed PMID: 32045288.
  2. Jiajue R, Feng K, Wang R, Xia W. Recurrent Femoral Fractures in a Boy with an Atypical Progeroid Syndrome: A Case Report. Calcif Tissue Int. 2020 Mar;106(3):325-330. doi: 10.1007/s00223-019-00639-5. Epub 2019 Dec 5. PubMed PMID: 31807803.
  3. Li X, Jiang Y, Huo L, Wu H, Liu Y, Jin J, Yu W, Lv W, Zhou L, Xia Y, Wang O, Li M, Xing X, Chi Y, Jiajue R, Cui L, Meng X, Xia W. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study. J Bone Miner Res. 2020 Mar;35(3):469-477. doi: 10.1002/jbmr.3903. Epub 2019 Nov 15. PubMed PMID: 31643101.
  4. Zheng WB, Li LJ, Zhao DC, Wang O, Jiang Y, Xia WB, Xing XP, Li M. Novel variants in COL2A1 causing rare spondyloepiphyseal dysplasia congenita. Mol Genet Genomic Med. 2020 Mar;8(3):e1139. doi: 10.1002/mgg3.1139. Epub 2020 Jan 23. PubMed PMID: 31972903; PubMed Central PMCID: PMC7057085.
  5. Yu W, Zhang ZZ, Wang O, Huang MQ, Xia WB, Guermazi A. Ring sign: an imaging sign for osteochondromyxoma in Carney complex. Quant Imaging Med Surg. 2019 Dec;9(12):1958-1965. doi: 10.21037/qims.2019.11.14. PubMed PMID: 31929968; PubMed Central PMCID: PMC6942971.
Year - 2019
  1. Chi Y, Sun J, Pang L, Jiajue R, Jiang Y, Wang O, Li M, Xing X, Hu Y, Zhou X, Meng X, Xia W*. Mutation update and long-term outcome after treatment with active vitamin D3 in Chinese patients with pseudovitamin D-deficiency rickets (PDDR). Osteoporos Int, 2019, 30(2):481-489.
  2. Jiajue R, Jiang Y, Qi X, Wang Q, Wang W, Pei Y, Wang X, Huang W, Zheng X, Ning Z, Wang O, Li M, Xing X, Yu W, Xu L, Xia W*. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study. Calcif Tissue Int. 2019 Jun;104(6):622-630. doi: 10.1007/s00223-019-00531-2. Epub 2019 Feb 8. PubMed PMID: 30737534.
  3. Jiajue R, Qi X, Jiang Y, Wang Q, Wang W, Pei Y, Wang X, Huang W, Zheng X, Ning Z, Wang O, Li M, Xing X, Yu W, Xu L, Xia W*. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study. Calcif Tissue Int. 2019 Nov;105(5):466-475. doi: 10.1007/s00223-019-00598-x. Epub 2019 Aug 27. PubMed PMID: 31511960.
  4. Jiang Y, Du J, Song YW, Wang WB, Pang QQ, Li M, Wang O, Lian XL, Xing XP, Xia WB*. Novel SLCO2A1compound heterozygous mutation causing primary hypertrophic osteoarthropathy with Bartter-like hypokalemia in a Chinese family. J Endocrinol Invest, 2019, doi: 10.1007/s40618-019-01048-z.
  5. Jiang Y, Tang H, Ma X, Cheng Q, Lin H, Jin X, Zhang Z, Yu W, He S, Kobayashi T, Uehara S, Matsumoto T, Xia W*. Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation. J Bone Miner Metab. 2019 Nov;37(6):1036-1047. doi: 10.1007/s00774-019-01009-9. Epub
  6. Li L, Zhao D, Zheng W, Wang O, Jiang Y, Xia W, Xing X, Li M. A novel missense mutation in P4HB causes mild osteogenesis imperfecta. Biosci Rep. 2019 Apr 30;39(4). pii: BSR20182118. doi: 10.1042/BSR20182118. Print 2019 May 31. PubMed PMID: 30948499; PubMed Central PMCID: PMC6499448.
  7. Li LJ, Lyu F, Song YW, Wang O, Jiang Y, Xia WB, Xing XP, Li M. Genotype-phenotype relationship in a large cohort of osteogenesis imperfecta patients with COL1A1 mutations revealed by a new scoring system. Chin Med J (Engl), 2019, 132(2):145-153.
  8. Li LJ, Zheng WB, Zhao DC, Yu W, Wang O, Jiang Y, Xia WB, Li M. Effects of zoledronic acid on vertebral shape of children and adolescents with osteogenesis imperfecta. Bone, 2019, 127:164-171.
  9. Liu C, Zhao Z, Wang O, Li M, Xing X, Hsieh E, Fukumoto S, Jiang Y, Xia W*. Earlier Onset in Autosomal Dominant Hypophosphatemic Rickets of R179 than R176 Mutations in Fibroblast Growth Factor 23: Report of 20 Chinese Cases and Review of the Literature. Calcif Tissue Int. 2019 Nov;105(5):476-486. doi: 10.1007/s00223-019-00597-y. Epub 2019 Sep 5. PubMed PMID: 31486862.
  10. Liu JM, Zhu DL, Mu YM, Xia WB*, Chinese Society of Osteoporosis and Bone Mineral Research, the Chinese Society of Endocrinology, Chinese Diabetes Society, Chinese Medical Association, Chinese Endocrinologist Association, Chinese Medical Doctor Association. Management of fracture risk in patients with diabetes-Chinese Expert Consensus. J Diabetes, 2019, doi: 10.1111/1753-0407.12962
  11. Liu S, Zhou X, Song A, Huo Z, Wang Y, Xia W*, Liu Y. Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot. Medicine (Baltimore). 2019 Jul;98(27):e16296. doi: 10.1097/MD.0000000000016296. PubMed PMID: 31277164; PubMed Central PMCID: PMC6635285.
  12. Pang Q, Xu Y, Qi X, Jiang Y, Wang O, Li M, Xing X, Qin L, Xia W*. The first case of primary hypertrophic osteoarthropathy with soft tissue giant tumors caused by HPGD loss-of-function mutation. Endocr Connect. 2019 Jun;8(6):736-744. doi: 10.1530/EC-19-0149. PubMed PMID: 31063976; PubMed Central PMCID: PMC6547301.
  13. Si N, Meng X, Zhao Z, Xia W*, Zhang X. A 105kb interstitial insertion in the Xq27.1 palindrome from pseudoautosomal region PAR1 causes a novel X-linked recessive compound phenotype. J Transl Med. 2019 Apr 29;17(1):138. doi: 10.1186/s12967-019-1887-2. PubMed PMID: 31036090; PubMed Central PMCID: PMC6489244.
  14. Song A, Wang W, Chen S, Wang Y, Liu S, Nie M, Jiang Y, Li M, Xia W, Meng X, Xing X, Wang O. PRIMARY HYPERPARATHYROIDISM DURING PREGNANCY: A CASE SERIES OF 8 PATIENTS. Endocr Pract. 2019 Nov;25(11):1127-1136. doi: 10.4158/EP-2019-0035. Epub 2019 Aug 15. PubMed PMID: 31414909.
  15. Song Y, Zhao D, Li L, Lv F, Wang O, Jiang Y, Xia W, Xing X, Li M. Health-related quality of life in children with osteogenesis imperfecta: a large-sample study. Osteoporos Int, 2019, 30(2):461-468.
  16. Wang Q, Li YH, Lin GL, Li Y, Zhou WX, Qian JM, Xia WB*, Wu D. Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature. Orphanet J Rare Dis. 2019 Dec 26;14(1):297. doi: 10.1186/s13023-019-1264-5. PubMed PMID: 31878983; PubMed Central PMCID: PMC6933916.
  17. Wang Y, Nie M, Wang O, Li Y, Jiang Y, Li M, Xia W, Xing X. Genetic Screening in a Large Chinese Cohort of Childhood Onset Hypoparathyroidism by Next-Generation Sequencing Combined with TBX1-MLPA. J Bone Miner Res. 2019 Dec;34(12):2254-2263. doi: 10.1002/jbmr.3854. Epub 2019 Nov 13. PubMed PMID: 31433868.
  18. Wang Y, Wang O, Jiang Y, Li M, Xia W, Meng X, Xing X. EFFICACY AND SAFETY OF BISPHOSPHONATE THERAPY IN MCCUNE-ALBRIGHT SYNDROME-RELATED POLYOSTOTIC FIBROUS DYSPLASIA: A SINGLE-CENTER EXPERIENCE. Endocr Pract. 2019 Jan;25(1):23-30. doi: 10.4158/EP-2018-0328. Epub 2018 Nov 1. PubMed PMID: 30383490.
  19. Wu CH, Chang YF, Chen CH, Lewiecki EM, Wüster C, Reid I, Tsai KS, Matsumoto T, Mercado-Asis LB, Chan DC, Hwang JS, Cheung CL, Saag K, Lee JK, Tu ST, Xia W, Yu W, Chung YS, Ebeling P, Mithal A, Ferrari SL, Cooper C, Lin GT, Yang RS. Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region. J Clin Densitom. 2019 Mar 20. pii: S1094-6950(19)30036-8. doi: 10.1016/j.jocd.2019.03.004. [Epub ahead of print] PubMed PMID: 31010789.
  20. Xia W, Cooper C, Li M, Xu L, Rizzoli R, Zhu M, Lin H, Beard J, Ding Y, Yu W, Cavalier E, Zhang Z, Kanis JA, Cheng Q, Wang Q, Reginster JY. East meets West: current practices and policies in the management of musculoskeletal aging. Aging Clin Exp Res. 2019 Oct;31(10):1351-1373. doi: 10.1007/s40520-019-01282-8. Epub 2019 Aug 2. Review. PubMed PMID: 31376119; PubMed Central PMCID: PMC6763533.
  21. Xie Z, Xia W, Zhang Z, Wu W, Lu C, Tao S, Wu L, Gu J, Chandler J, Peter S, Yuan H, Wu T, Liao E. Prevalence of Vitamin D Inadequacy Among Chinese Postmenopausal Women: A Nationwide, Multicenter, Cross-Sectional Study. Front Endocrinol (Lausanne). 2019 Jan 7;9:782. doi: 10.3389/fendo.2018.00782. eCollection 2018. PubMed PMID: 30666233; PubMed Central PMCID: PMC6330713.
  22. Xu XJ, Lv F, Song YW, Li LJ, Asan, Wei XX, Zhao XL, Jiang Y, Wang O, Xing XP, Xia WB, Li M. Novel mutations in BMP1 induce a rare type of osteogenesis imperfecta. Clin Chim Acta, 2019, 489:21-28. doi: 10.1016/j.cca.2018.11.004.
  23. Yang H, Yan K, Yuping X, Zhang Q, Wang L, Gong F, Zhu H, Xia W*, Pan H. Bone microarchitecture and volumetric bone density impairment in young male adults with childhood-onset growth hormone deficiency. Eur J Endocrinol. 2019 Feb 1;180(2):145-153. doi: 10.1530/EJE-18-0711. PubMed PMID: 30481154; PubMed Central PMCID: PMC6347261.
  24. Yu F, Xia W*. The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos. 2019 Mar 8;14(1):32. doi: 10.1007/s11657-018-0549-y. Review. PubMed PMID: 30848398.
  25. Yu J, Ping F, Zhang H, Li W, Yuan T, Fu Y, Feng K, Xia W, Xu L, Li Y. Clinical Management of Malignant Insulinoma: a single Institution's experience over three decades. BMC Endocr Disord. 2018 Dec 6;18(1):92. doi: 10.1186/s12902-018-0321-8. PubMed PMID: 30522468; PubMed Central PMCID: PMC6282250.
  26. Zhang C, Zhao Z, Sun Y, Xu L, JiaJue R, Cui L, Pang Q, Jiang Y, Li M, Wang O, He X, He S, Nie M, Xing X, Meng X, Zhou X, Yan L, Kaplan JM, Insogna KL, Xia W*. Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone. 2019 Apr;121:212-220. doi: 10.1016/j.bone.2019.01.021. Epub 2019 Jan 23. PubMed PMID: 30682568.
Year - 2018
  1. Chan DD, Chang LY, Akesson KE, Mitchell P, Chen CH, Lewiecki EM, Lee JK, Lau TC, Songpatanasilp T, Lee KB, Kim KJ, Chen JF, Huang KE, Gau YL, Chang YF, Ebeling P, Xia W, Yu W, Suzuki A, Hew FL, Mercado-Asis LB, Chung YS, Tsai KS, Lin GT, Yang RS, Wu CH. Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region. Arch Osteoporos. 2018 May 12;13(1):59. doi: 10.1007/s11657-018-0463-3. Review. Erratum in: Arch Osteoporos. 2018 Jul 3;13(1):73. PubMed PMID: 29754189.
  2. Cheung CL, Ang SB, Chadha M, Chow ES, Chung YS, Hew FL, Jaisamrarn U, Ng H, Takeuchi Y, Wu CH, Xia W, Yu J, Fujiwara S. An updated hip fracture projection in Asia: The Asian Federation of Osteoporosis Societies study. Osteoporos Sarcopenia, 2018, 4(1):16-21.
  3. Chu X, Zhu Y, Wang O, Nie M, Quan T, Xue Y, Wang W, Jiang Y, Li M, Xia W, Xing X. Clinical and genetic characteristics of Pseudohypoparathyroidism in the Chinese population. Clin Endocrinol (Oxf). 2018 Feb;88(2):285-294. doi: 10.1111/cen.13516. Epub 2017 Dec 14. PubMed PMID: 29136292.
  4. Cui L, Xu Y, Xu Q, Jiang Y, Wang O, Li M, Xing X, Xia W*. Atypical Femoral Fracture Associated With Overuse of Bisphosphonate Evaluated by High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT): A Case Report. J Clin Densitom. 2018 Jul 29. pii: S1094-6950(18)30084-2. doi: 10.1016/j.jocd.2018.07.009. [Epub ahead of print] PubMed PMID: 30172602.
  5. Du J, Jiang Y, Wang O, Li M, Xing XP, Xia W*. URAT1 mutations cause renal hypouricaemia combined with Fanconi syndrome in a Chinese patient. Nephrology (Carlton). 2018 Aug;23(8):797-798. doi: 10.1111/nep.13190. PubMed PMID: 30920107.
  6. Hou Y, Lin Y, Qi X, Yuan L, Liao R, Pang Q, Cui L, Jiang Y, Wang O, Li M, Dong J, Xia W*. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study. Bone. 2018 Jan;106:96-102. doi: 10.1016/j.bone.2017.09.015. Epub 2017 Sep 28. PubMed PMID: 28963081.
  7. Hsieh E, Wang Q, Zhang R, Niu X, Xia W, Fraenkel L, Insogna KL, Li J, Smith JS, Zhou C, Qiao YL, Zhang P. Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps. BMC Cancer. 2018 Jan 30;18(1):104. doi: 10.1186/s12885-018-4014-5. PubMed PMID: 29378534; PubMed Central PMCID: PMC5789645.
  8. Jiang N, Xia W*. Assessment of bone quality in patients with diabetes mellitus. Osteoporos Int, 2018,29(8):1721-1736.
  9. Li LJ, Zhang J, Gao P, Lv F, Song YW, Chang XY, Zhao DC, Wang O, Jiang Y, Xing XP, Xia WB, Li M. Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol, 2018, 37(11):3141-3150.
  10. Li N, Jiang Y, He S, Zhao Z, Sun J, Li M, Wang O, Xing X, Xia W*. Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study. Medicine (Baltimore). 2018 Nov;97(47):e13159. doi: 10.1097/MD.0000000000013159. PubMed PMID: 30461612; PubMed Central PMCID: PMC639305
  11. Liao EY, Zhang ZL, Xia WB*, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, Peng YD, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal. BMC Musculoskelet Disord, 2018, 19(1):210.
  12. Liao EY, Zhang ZL, Xia WB*, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, Peng YD, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L. Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China. Medicine (Baltimore), 2018, 97(31):e11694.
  13. Lv F, Guan Y, Ma D, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X, Li M. Effects of alendronate and alfacalcidol on bone in patients with myasthenia gravis initiating glucocorticoids treatment. Clin Endocrinol (Oxf). 2018 Mar;88(3):380-387. doi: 10.1111/cen.13537. Epub 2018 Jan 12. PubMed PMID: 29266368.
  14. Lv F, Liu Y, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X. ZOLEDRONIC ACID VERSUS ALENDRONATE IN THE TREATMENT OF CHILDREN WITH OSTEOGENESIS IMPERFECTA: A 2-YEAR CLINICAL STUDY. Endocr Pract. 2018 Feb;24(2):179-188. doi: 10.4158/EP171910.OR. PubMed PMID: 29466057.
  15. Lv F, Xu X, Song Y, Li L, Asan, Wang J, Yang H, Wang O, Jiang Y, Xia W, Xing X, Li M. Novel Mutations in PLOD2 Cause Rare Bruck Syndrome. Calcif Tissue Int, 2018,102(3):296-309.
  16. Song Y, Zhao D, Xu X, Lv F, Li L, Jiang Y, Wang O, Xia W, Xing X, Li M. Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X. Osteoporos Int, 2018, 29(6):1389-1396.
  17. Wang JY, Li LJ, Zhang Q, Liu Y, Lv F, Xu XJ, Song YW, Wang O, Jiang Y, Xia WB, Xing XP, Li M. Extremely low level of serum pigment epithelium-derived factor is a special biomarker of Chinese osteogenesis imperfecta patients with SERPINF1 mutations. Clin Chim Acta,2018, 478:216-221.
  18. Xu L, Pang Q, Jiang Y, Wang O, Li M, Xing X, Xia W. Four novel mutations in the ALPL gene in Chinese patients with odonto, childhood, and adult hypophosphatasia. Biosci Rep. 2018 Aug 29;38(4). pii: BSR20171377. doi: 10.1042/BSR20171377. Print 2018 Aug 31. PubMed PMID: 29724887; PubMed Central PMCID: PMC6131208.
  19. Xu XJ, Lv F, Song YW, Li LJ, Asan, Wei XX, Zhao XL, Jiang Y, Wang O, Xing XP, Xia WB, Li M. Novel mutations in BMP1 induce a rare type of osteogenesis imperfecta. Clin Chim Acta, 2019, 489:21-28.
  20. Yin Z, Du J, Yu F, Xia W*. Tumor-induced osteomalacia. Osteoporos Sarcopenia, 2018,4(4):119-127.
  21. Yu J, Ping F, Zhang H, Li W, Yuan T, Fu Y, Feng K, Xia W, Xu L, Li Y. Clinical Management of Malignant Insulinoma: a single Institution's experience over three decades. BMC Endocr Disord, 2018, 18(1):92.
Year - 2017
  1. Chu XY, Li YP, Nie M, Wang O, Jiang Y, Li M, Xia WB, Xing XP. A Novel De novo GATA-binding Protein 3 Mutation in a Patient with Hypoparathyroidism, Sensorineural Deafness, and Renal Dysplasia Syndrome. Chin Med J (Engl), 2017, 130(11):1378-1380.
  2. Feng J,Jiang Y,Wang O,Li M,Xing X,Huo L,Li F,Yu W,Zhong DR,Jin J,Liu Y,Qi F,Lv W,Zhou L,Meng XW,Xia WB. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J, 2017, 64(7):675-683.
  3. Wang W, Kong J, Nie M, Jiang Y, Li M, Xia W, Meng X, Xing X, Wang O. Primary hyperparathyroidism in Chinese children and adolescents: A single-centre experience at Peking Union Medical College Hospital. Clin Endocrinol (Oxf), 2017, 87(6):865-873.
  4. Xu XJ, Lv F, Liu Y, Wang JY, Ma DD, Asan, Wang JW, Song LJ, Jiang Y, Wang O, Xia WB, Xing XP, Li M. Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid. J Hum Genet, 2017,62(2):205-211.
  5. Wang JY, Liu Y, Song LJ, Lv F, Xu XJ, San A, Wang J, Yang HM, Yang ZY, Jiang Y, Wang O, Xia WB, Xing XP, Li M. Novel Mutations in SERPINF1 Result in Rare Osteogenesis Imperfecta Type VI. Calcif Tissue Int, 2017, 100(1):55-66.
  6. Lv F, Xu XJ, Song YW, Li LJ, Wang O, Jiang Y, Xia WB, Xing XP, Gao P, Li M. Recurrent and novel mutations in the NTRK1 gene lead to rare congenital insensitivity to pain with anhidrosis in two Chinese patients. Clin Chim Acta, 2017, 468:39-45.
  7. Cui L, Chen L, Xia W, Jiang Y, Cui L, Huang W, Wang W, Wang X, Pei Y, Zheng X, Wang Q, Ning Z, Li M, Wang O, Xing X, Lin Q, Yu W, Weng X, Xu L, Cummings SR. Vertebral fracture in postmenopausal Chinese women: a population-based study. Osteoporos Int, 2017,28(9):2583-2590.
  8. Wu B, Wang O, Jiang Y, Li M, Xing X, Xia W. Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient. Bone Res, 2017, 5:17001.
  9. Xu L, Niu M, Yu W, Xia W, Gong F, Wang O. Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria. J Diabetes Complications, 2017,31(3):583-588.
  10. Lv F, Xu X, Song Y, Li L, Asan, Wang J, Yang H, Wang O, Jiang Y, Xia W, Xing X, Li M. Novel Mutations in PLOD2 Cause Rare Bruck Syndrome. Calcif Tissue Int, 2018 Mar;102(3):296-309.
  11. Guan Y, Lv F, Meng Y, Ma D, Xu X, Song Y, Wang O, Jiang Y, Xia W, Xing X, Zhang J, Li M. Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study. Osteoporos Int, 2017, 28(8):2383-2390.
  12. Hou Y, Lin Y, Qi X, Yuan L, Liao R, Pang Q, Cui L, Jiang Y, Wang O, Li M, Dong J, Xia W. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study. Bone, 2018, 106:96-102.
  13. Liu Y, Asan, Ma D, Lv F, Xu X, Wang J, Xia W, Jiang Y, Wang O, Xing X, Yu W, Wang J, Sun J, Song L, Zhu Y, Yang H, Wang J, Li M. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int, 2017, 28(10):2985-2995.
  14. Pang R, Xia W. Pharmacological Treatment of Bone Loss. Curr Pharm Des, 2017, 23(41):6298-6301.
  15. Wang JY, Li LJ, Zhang Q, Liu Y, Lv F, Xu XJ, Song YW, Wang O, Jiang Y, Xia WB, Xing XP, Li M. Extremely low level of serum pigment epithelium-derived factor is a special biomarker of Chinese osteogenesis imperfecta patients with SERPINF1 mutations. Clin Chim Acta, 2018, 478:216-221.
  16. Lv F, Ma M, Liu W, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X, Qiu Z, Li M. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Osteoporos Int, 2017, 28(9):2691-2700.
  17. Qi X, Pang Q, Wang J, Zhao Z, Wang O, Xu L, Mao J, Jiang Y, Li M, Xing X, Yu W, Asan, Xia W. Familial Early-Onset Paget's Disease of Bone Associated with a Novel hnRNPA2B1 Mutation. Calcif Tissue Int, 2017, 101(2):159-169.
  18. Yeap SS, Jaisamrarn U, Park YS, Takeuchi Y, Xia W; AFOS Call-To-Action Committee. The Asian Federation of Osteoporosis Societies' call to action to improve the undertreatment of osteoporosis in Asia. Osteoporos Sarcopenia, 2017, 3(4):161-163.
Year - 2016
  1. Liu Y, Zhong DR, Zhou PR, Lv F, Ma DD, Xia WB, Jiang Y, Wang O, Xing XP, Li M. Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature. Clin Rheumatol, 2016, 35(3):813-823.
  2. Liu L, Pang Q, Jiang Y, Li M, Wang O, Xia W. Novel COL2A1 mutations causing spondyloepiphyseal dysplasia congenita in three unrelated Chinese families. Eur Spine J, 2016,25(9):2967-74. doi: 10.1007/s00586-016-4559-4
  3. Li M, Lv F, Zhang Z, Deng W, Li Y, Deng Z, Jiang Y, Wang O, Xing X, Xu L, Xia W. Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density. Osteoporos Int, 2016, 27(5):1907-1916.
  4. Chen J, Li K, Pang Q, Yang C, Zhang H, Wu F, Cao H, Liu H, Wan Y, Xia W, Wang J, Dai Z, Li Y. Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis. Sci Rep, 2016, 6:36347.
  5. Wu B, Jiang Y, Wang O, Li M, Xing XP, Xia WB. Craniometaphyseal dysplasia with obvious biochemical abnormality and rickets-like features. Clin Chim Acta, 2016, 456:122-127.
  6. Liu Y, Wang J, Ma D, Lv F, Xu X, Xia W, Jiang Y, Wang O, Xing X, Zhou P, Wang J, Yu W, ASAN, Li M. Osteogenesis imperfecta type V: Genetic and clinical findings in eleven Chinese patients. Clin Chim Acta, 2016, 462:201-209.
  7. Kong J, Wang O, Nie M, Shi J, Hu Y, Jiang Y, Li M, Xia W, Meng X, Xing X. Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese. PLoS One, 2016, 11(11):e0166634.
  8. Lv F, Xu XJ, Wang JY, Liu Y, Asan, Wang JW, Song LJ, Song YW, Jiang Y, Wang O, Xia WB, Xing XP, Li M . Two novel mutations in TMEM38B result in rare autosomal recessive osteogenesis imperfecta. J Hum Genet. 2016, 61(6):539-545.
  9. Pang Q, Chi Y, Zhao Z, Xing X, Li M, Wang O, Jiang Y, Liao R, Sun Y, Dong J, Xia W. Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients. Osteoporos Int, 2016, 27(3):1047-1055.
  10. Shi C, Wang F, Tong A, Zhang XQ, Song HM, Liu ZY, Lyu W, Liu YH, Xia WB. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: A case report and review of literature. Medicine (Baltimore), 2016,95(40):e5081.
  11. Liu Y, Song L, Ma D, Lv F, Xu X, Wang J, Xia W, Jiang Y, Wang O, Song Y, Xing X, Asan, Li M. Genotype-phenotype analysis of a rare type of osteogenesis imperfecta in four Chinese families with WNT1 mutations. Clin Chim Acta, 2016, 461:172-180.
  12. Pang Q, Qi X, Jiang Y, Wang O, Li M, Xing X, Dong J, Xia W. Clinical and genetic findings in a Chinese family with VDR-associated hereditary vitamin D-resistant rickets. Bone Res, 2016, 4:16018.
  13. Jiajue R, Wu B, Jiang Y, Wang O, Li M, Xing X, Xia W. Mild Camurati‑Engelamann disease presenting with exophthalmos as the first and only manifestation: A case report. Mol Med Rep, 2016, 14(3):2710-2716.
  14. Hsieh E, Fraenkel L, Han Y, Xia W, Insogna KL, Yin MT, Zhu T, Cheng X, Li T. Longitudinal increase in vitamin D binding protein levels after initiation of tenofovir/lamivudine/efavirenz among individuals with HIV. AIDS，2016, 30(12):1935-1942.
  15. Myers EJ, Yuan L, Felmlee MA, Lin YY, Jiang Y, Pei Y, Wang O, Li M, Xing XP, Marshall A, Xia WB, Parker MD. A novel mutant Na+ /HCO3- cotransporter NBCe1 in a case of compound-heterozygous inheritance of proximal renal tubular acidosis. J Physiol, 2016, 594(21):6267-6286.
  16. Lv F, Xu XJ, Wang JY, Liu Y, Jiang Y, Wang O, Xia WB, Xing XP, Li M. A novel mutation in CLDN16 results in rare familial hypomagnesaemia with hypercalciuria and nephrocalcinosis in a Chinese family. Clin Chim Acta, 2016, 457:69-74.
  17. Xu XJ, Lv F, Liu Y, Wang JY, Song YW, Asan, Wang JW, Song LJ, Jiang Y, Wang O, Xia WB, Xing XP, Li M. A cryptic balanced translocation involving COL1A2 gene disruption cause a rare type of osteogenesis imperfecta. Clin Chim Acta, 2016, ;460:33-39.
  18. Wang JY, Zhou PR, Liu Y, Xu XJ, Ma DD, Xia WB, Jiang Y, Wang O, Xing XP, Li M. The analysis of DKK1 polymorphisms in relation to skeletal phenotypes and bone response to alendronate treatment in Chinese postmenopausal women. Pharmacogenomics. 2016, 17(3):209-217.
  19. Xu XJ, Ma DD, Lv F, Wang JY, Liu Y, Xia WB, Jiang Y, Wang O, Xing XP, Yu W, Li M. The Clinical Characteristics and Efficacy of Bisphosphonates in Adult Patients with Osteogenesis Impergecta. Endocr Pract, 2016, 22(11):1267-1276.
Year - 2015
  1. Yuan L, Chen L, Liao RX, Lin YY, Jiang Y, Wang O, Li M, Xing XP, Pang QQ, Jiajue R, Xia WB. A Common Mutation and a Novel Mutation in the HPGD Gene in Nine Patients with Primary Hypertrophic Osteoarthropathy. Calcif Tissue Int, 2015, 97(4):336-342.
  2. Ning Z, Wang O, Meng X, Xing X, Xia W, Jiang Y, Li M, Xu Y. MEN1 c.825‑1G A mutation in a family with multiple endocrine neoplasia type 1: A case report. Mol Med Rep, 2015, 12(4):6152-6156.
  3. Gu JM, Wang L, Lin H, Chen DC, Tang H, Jin XL, Xia WB, Hu YQ, Fu WZ, He JW, Zhang H, Wang C, Yue H, Hu WW, Liu YJ, Zhang ZL .The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data. Acta Pharmacol Sin, 2015, 36(7):841-846.
  4. Wang O, Hu Y, Gong S, Xue Q, Deng Z, Wang L, Liu H, Tang H, Guo X, Chen J, Jia X, Xu Y, Lan L, Lei C, Dong H, Yuan G, Fu Q, Wei Y, Xia W, Xu L. A survey of outcomes and management of patients post fragility fractures in China. Osteoporos Int, 2015, 26(11):2631-2640.
  5. Zhou PR, Xu XJ, Zhang ZL, Liao EY, Chen DC, Liu J, Wu W, Jiang Y, Wang O, Xia WB, Xing XP, Xu L, Li M. SOST polymorphisms and response to alendronate treatment in postmenopausal Chinese women with osteoporosis. Pharmacogenomics, 2015, 16(10):1077-1088.
  6. Wang H, Zhong D, Liu Y, Jiang Y, Qiu G, Weng X, Xing X, Li M, Meng X, Li F, Zhu Z, Yu W, Xia W, Jin J. Surgical Treatments of Tumor-Induced Osteomalacia Lesions in Long Bones: Seventeen Cases with More Than One Year of Follow-up. J Bone Joint Surg Am, 2015, 97(13):1084-1094.
  7. Hsieh E, Fraenkel L, Xia W, Hu YY, Han Y, Insogna K, Yin MT, Xie J, Zhu T, Li T. Increased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIV. Osteoporos Int, 2015, 26(3):1035-1044.
  8. Chen Z, Wang O, Nie M, Elison K, Zhou D, Li M, Jiang Y, Xia W, Meng X, Chen S, Xing X. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism. Mol Cell Endocrinol, 2015, 399:32-42.
  9. Xu L, Xia W, Wu X, Wang X, Zhao L, Nie M. Chimeric CYP11B2/CYP11B1 causing 11β-hydroxylase deficiency in Chinese patients with congenital adrenal hyperplasia. Steroids, 2015, 101:51-55.
  10. Yuan T, Pang Q, Xing X, Wang X, Li Y, Li J, Wu X, Li M, Wang O, Jiang Y, Dong J, Xia W. First report of a novel missense CLDN19 mutations causing familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a Chinese family. Calcif Tissue Int, 2015, 96(4):265-273.
  11. Huang X, Qi X, Li M, Wang O, Jiang Y, Xing X, Hu YY, Xia W. A Mutation in CTSK Gene in an Autosomal Recessive Pycnodysostosis Family of Chinese Origin. Calcif Tissue Int, 2015, 96(5):373-278.
  12. Pang Q, Qi X, Jiang Y, Wang O, Li M, Xing X, Dong J, Xia W. Two novel CAII mutations causing carbonic anhydrase II deficiency syndrome in two unrelated Chinese families. Metab Brain Dis, 2015, 30(4):989-997.
  13. Xu LJ, Jiang Y, Liao RX, Zhang HB, Mao JF, Chi Y, Li M, Wang O, Liu XQ, Liu ZY, Xing XP, Yu W, Xia WB. Low-dose adefovir dipivoxil may induce Fanconi syndrome: clinical characteristics and long-term follow-up for Chinese patients. Antivir Ther, 2015, 20(6):603-611.
  14. Jiang Y, Fu Y, Xing XP, Li M, Wang O, Xia WB, Meng XW. Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis. Eur J Med Res, 2015, 20:68.
  15. Liu L, Li N, Zhao Z, Li W, Xia W. Novel WISP3 mutations causing spondyloepiphyseal dysplasia tarda with progressive arthropathy in two unrelated Chinese families. Joint Bone Spine, 2015, 82(2):125-128.
  16. Zhang ZL, Liao EY, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, De Peng Y, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L, Santora AC. Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension. Osteoporos Int, 2015, 26(9):2365-2374.
Year - 2014
  1. Hsieh E, Fraenkel L, Bradley EH, Xia W, Insogna KL, Cui Q, Li K, Li T. Osteoporosis knowledge, self-efficacy, and health beliefs among Chinese individuals with HIV. Arch Osteoporos, 2014, 9:201.
  2. Liao RX, Yu M, Jiang Y, Xia W. Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review. Clin Interv Aging, 2014, 9:515-526.
  3. Zhou PR, Liu HJ, Liao EY, Zhang ZL, Chen DC, Liu J, Wu W, Xing XP, Xia WB, Xu L, Li M. LRP5 polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis. Pharmacogenomics, 2014, 15(6):821-831.
  4. Li M, Li Y, Deng W, Zhang Z, Deng Z, Hu Y, Xia W, Xu L. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender. PLoS One, 2014, 9(8):e103841.
  5. Zhao J, Hu Y, Liao Q, Niu Z, Xing X, Xia W, Zhao Y. Gene identification of potential malignant parathyroid tumors phenotype in Chinese population. Endocr J, 2014, 61(6):597-605.
  6. Kong J, Wang O, Nie M, Shi J, Hu Y, Jiang Y, Li M, Xia W, Meng X, Xing X. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese. Clin Endocrinol (Oxf), 2014, 81(2):222-230.
  7. Jiajue R, Jiang Y, Wang O, Li M, Xing X, Cui L, Yin J, Xu L, Xia W. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus. Osteoporos Int, 2014, 25(8):1999-2005.
  8. Xu W, Sun J, Wang W, Wang X, Jiang Y, Huang W, Zheng X, Wang Q, Ning Z, Pei Y, Nie M, Li M, Wang O, Xing X, Yu W, Lin Q, Xu L, Xia W. Association of genetic variants of vit D binding protein (DBP/GC) and of the enzyme catalyzing its 25-hydroxylation (DCYP2R1) and serum vit D in postmenopausal women. Hormones (Athens), 2014, 13(3):345-352.
  9. Li N, Wang X, Jiang Y, Wang W, Huang W, Zheng X, Wang Q, Ning Z, Pei Y, Li C, Nie M, Li M, Wang O, Xing X, He S, Yu W, Lin Q, Xu L, Xia W. Association of GALNT3 gene polymorphisms with bone mineral density in Chinese postmenopausal women: the Peking Vertebral Fracture study. Menopause, 2014, 21(5):515-521.
  10. Chi Y, Zhao Z, He X, Sun Y, Jiang Y, Li M, Wang O, Xing X, Sun AY, Zhou X, Meng X, Xia W. A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient. Bone, 2014, 59:114-121.
  11. Li N, Nie M, Li M, Jiang Y, Xing X, Wang O, Li C, Xia W. The first mutation identified in a Chinese acrodysostosis patient confirms a p.G289E variation of PRKAR1A causes acrodysostosis. Int J Mol Sci, 2014, 15(8):13267-13274.
  12. Zhou P, Liu Y, Lv F, Nie M, Jiang Y, Wang O, Xia W, Xing X, Li M. Novel mutations in FKBP10 and PLOD2 cause rare Bruck syndrome in Chinese patients. PLoS One, 2014, 9(9):e107594.
Year - 2013
  1. Huang X, Jiang Y, Xia W. FGF23 and Phosphate Wasting Disorders. Bone Res, 2013, 1(2):120-132.
  2. Tong A, Xia W, Qi F, Jin Z, Yang D, Zhang Z, Li F, Xing X, Lian X. Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx: a case report and review of the literature. Thyroid, 2013, 23(9):1172-1177.
  3. Zhao Z, Pei Y, Huang X, Liu Y, Yang W, Sun J, Si N, Xing X, Li M, Wang O, Jiang Y, Zhang X, Xia W. Novel TRPM6 mutations in familial hypomagnesemia with secondary hypocalcemia. Am J Nephrol, 2013, 37(6):541-548.
  4. Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis. Menopause, 2013, 20(1):72-78.
Year - 2012
  1. Jiang Y, Xia WB, Xing XP, Silva BC, Li M, Wang O, Zhang HB, Li F, Jing HL, Zhong DR, Jin J, Gao P, Zhou L, Qi F, Yu W, Bilezikian JP, Meng XW. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res, 2012, 27(9):1967-1975.
  2. Wang O, Wang C, Nie M, Cui Q, Guan H, Jiang Y, Li M, Xia W, Meng X, Xing X. Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas. PLoS One, 2012, 7(9):e45567.
  3. Xia WB, He SL, Xu L, Liu AM, Jiang Y, Li M, Wang O, Xing XP, Sun Y, Cummings SR. Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res, 2012, 27(1):125-129.
  4. Sun Y, Wang O, Xia W, Jiang Y, Li M, Xing X, Hu Y, Liu H, Meng X, Zhou X. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets. J Bone Miner Metab, 2012, 30(1):78-84.
  5. Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Chen Q, Xu L. A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) study. Bone, 2012, 50(4):917-924.
  6. Sun J, Xia W, He S, Zhao Z, Nie M, Li M, Jiang Y, Xing X, Wang O, Meng X, Zhou X. Novel and recurrent mutations of WISP3 in two Chinese families with progressive pseudorheumatoid dysplasia. PLoS One, 2012, 7(6):e38643.
  7. Cui N, Xia W, Su H, Pang L, Jiang Y, Sun Y, Nie M, Xing X, Li M, Wang O, Yuan T, Chi Y, Hu Y, Liu H, Meng X, Zhou X. Novel mutations of CYP27B1 gene lead to reduced activity of 1α-hydroxylase in Chinese patients. Bone, 2012, 51(3):563-569.
Year - 2011
  1. Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Xu L. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study. Menopause, 2011, 18(11):1237-1243 [1] 

夏維波著作譯作

《絕經後骨質疏鬆症》主譯
《骨質疏鬆症診斷、預防、治療》副主譯 [1] 

夏維波科普宣傳

《骨質疏鬆症就醫指南》主編
國家科普專家庫第一批成員，主持開展北京協和醫院內分泌科科普“泌語協行”。多次在科普欄目主講科普知識。國家健康行動計劃顧問。 [3] 
參考資料